Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retrospective Study in China

BACKGROUND: This retrospective single-center study conducted in China aimed to investigate the clinical outcomes of patients with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer (MBC) treated with palbociclib plus endocrine thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Li, Ting, Tao, Zhonghua, Cao, Jun, Wang, Leiping, Zhang, Jian, Wang, Biyun, Hu, Xichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716621/
https://www.ncbi.nlm.nih.gov/pubmed/33250509
http://dx.doi.org/10.12659/MSM.927187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716621/
https://www.ncbi.nlm.nih.gov/pubmed/33250509
http://dx.doi.org/10.12659/MSM.927187

Ejemplares similares